50 /100
MEDIUM RISK
Score updated Jul 14, 2026

XRX — Xerox Holdings Corporation Dilution Risk Tracker

Track XRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track XRX — Get alerts when the score changes →

As of July 14, 2026, Xerox Holdings Corporation (XRX) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Xerox Holdings Corporation has a market capitalization of $423.73M, 130.78M shares outstanding, 233 institutional holders tracked. Key dilution vectors include shelf registration capacity of $750.00M, ATM program capacity of $750.00M, approximately 30 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
97
💰 Cash Runway
10
📊 Float Risk
17
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
28%
💰 Capital Raise 38%
• Active shelf registration ($750M, 177% of market cap)
• Active ATM program with $750M remaining capacity
🔄 Reverse Split 30%
• 50-day avg $1.97 approaching $1 threshold
🔔 Track XRX — Get forecast alerts →

💹 Market Data

Market Cap$423.73M
Shares Outstanding130.78M
Float120.60M
Cash$585.00M
Debt$4.45B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 3.3% shares (2026Q1 vs prior)
233 institutional holders · 134.90M shares
#1 GOLDMAN SACHS GROUP INC 12.73M shares
#2 BlackRock, Inc. 10.15M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 10.12M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest36.47M
Days to Cover8.5
% of Float30.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Feb 12, 2026
3 FORM3 Apr 08, 2026
3 FORM3 Apr 08, 2026
4 INSIDER TRANSACTION Mar 13, 2026
4 INSIDER TRANSACTION Mar 13, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for XRX Shareholders

Xerox Holdings Corporation (XRX) has a DilutionScore of 50/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

The most significant dilution vector for XRX is its shelf registration capacity of $750.0M. A shelf registration (typically an S-3 filing) gives a company pre-approved access to raise capital quickly without a traditional roadshow. The registered amount represents the maximum that can be raised — not necessarily what will be raised — but active shelves combined with tight cash positions are the pattern DilutionWatch monitors most closely. XRX has an active ATM (at-the-market) program with $750.0M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event.

DilutionWatch tracks over 25 SEC filing types for XRX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for XRX alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding Shelf Registrations → How ATM Offerings Work →
Track XRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking XRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for XRX
📊 XRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 XRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.